Get the Stockscreener App
1.74
5.45%
0.09
Whitehawk Therapeutics Inc stock is traded at $1.74, with a volume of 70,989.
It is up +5.45% in the last 24 hours and down -6.95% over the past month.
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.
See More
Previous Close:
$1.65
Open:
$1.68
24h Volume:
70,989
Relative Volume:
0.59
Market Cap:
$82.00M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+8.75%
1M Performance:
-6.95%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$1.68
$1.76
1-Week Range:
$1.57
$1.76
52-Week Range:
$1.39
$2.20
Whitehawk Therapeutics Inc Stock (WHWK) Company Profile
Name
Whitehawk Therapeutics Inc
Sector
Industry
Phone
551-321-2234
Address
2 HEADQUARTERS PLAZA, MORRISTOWN
Compare WHWK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WHWK
Whitehawk Therapeutics Inc
|
1.74 | 75.88M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Whitehawk Therapeutics Inc Stock (WHWK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-27-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-21-24 | Downgrade | Jefferies | Buy → Hold |
| Aug-21-24 | Downgrade | TD Cowen | Buy → Hold |
| Dec-15-23 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jan-11-22 | Initiated | Jefferies | Buy |
| Oct-01-21 | Initiated | Cowen | Outperform |
| Sep-14-21 | Initiated | Ladenburg Thalmann | Buy |
| Sep-08-21 | Initiated | Piper Sandler | Overweight |
View All
Whitehawk Therapeutics Inc Stock (WHWK) Latest News
Order flow analysis tools used on Whitehawk Therapeutics Inc.July 2025 Decliners & Reliable Momentum Entry Alerts - Newser
Signal strength of Whitehawk Therapeutics Inc. stock in tech scannersSwing Trade & Smart Investment Allocation Tips - Newser
Live market analysis of Whitehawk Therapeutics Inc.2025 Market Sentiment & Weekly Watchlist for Hot Stocks - Newser
Historical volatility pattern of Whitehawk Therapeutics Inc. visualizedCEO Change & Reliable Price Action Trade Plans - Newser
Chart overlay techniques for tracking Whitehawk Therapeutics Inc.2025 Earnings Surprises & Community Consensus Trade Alerts - Newser
Real time social sentiment graph for Whitehawk Therapeutics Inc.Weekly Investment Summary & Stock Timing and Entry Methods - Newser
What earnings revisions data tells us about Whitehawk Therapeutics Inc.Trade Ideas & Stepwise Trade Signal Implementation - Newser
Does Whitehawk Therapeutics Inc. fit your quant trading modelMarket Risk Summary & Entry Point Confirmation Alerts - Newser
Detecting support and resistance levels for Whitehawk Therapeutics Inc.2025 Momentum Check & Free Expert Verified Stock Movement Alerts - Newser
Pattern recognition hints at Whitehawk Therapeutics Inc. upside2025 Retail Activity & AI Driven Price Forecasts - Newser
Whitehawk Therapeutics Inc. stock volume spike explainedAnalyst Upgrade & Weekly Hot Stock Watchlists - Newser
Will breakout in Whitehawk Therapeutics Inc. lead to full recoveryMarket Trend Report & Weekly Top Stock Performers List - Newser
Ranking Whitehawk Therapeutics Inc. among high performing stocks via tools2025 Market Sentiment & Free High Accuracy Swing Entry Alerts - Newser
How to escape a deep drawdown in Whitehawk Therapeutics Inc.Profit Target & Fast Exit/Entry Strategy Plans - Newser
Published on: 2025-08-19 04:09:58 - Newser
Combining price and volume data for Whitehawk Therapeutics Inc.Jobs Report & Fast Entry Momentum Trade Alerts - Newser
Combining machine learning predictions for Whitehawk Therapeutics Inc.Weekly Trend Summary & Low Risk Entry Point Guides - Newser
Technical signs of recovery in Whitehawk Therapeutics Inc.Product Launch & Fast Exit and Entry Strategy Plans - Newser
What institutional flow reveals about Whitehawk Therapeutics Inc.Weekly Market Report & AI Forecasted Entry/Exit Points - Newser
Published on: 2025-08-17 00:31:41 - Newser
Backtesting results for Whitehawk Therapeutics Inc. trading strategiesSwing Trade & Reliable Volume Spike Alerts - Newser
Whitehawk Therapeutics Inc. Sees Relief Buying After Extended Drop2025 Market Trends & Weekly Top Performers Watchlists - newsimpact.co.kr
Whitehawk Therapeutics Inc. stock daily chart insightsJuly 2025 Closing Moves & Free Community Supported Trade Ideas - Newser
Automated trading signals detected on Whitehawk Therapeutics Inc.2025 Macro Impact & Short-Term High Return Strategies - Newser
Is Whitehawk Therapeutics Inc. stock a good pick for beginnersWeekly Trade Summary & Consistent Income Trade Ideas - mustnews.co.kr
What momentum shifts mean for Whitehawk Therapeutics Inc.Weekly Loss Report & Weekly Hot Stock Watchlists - Newser
Whitehawk Therapeutics Inc Stock (WHWK) Financials Data
There is no financial data for Whitehawk Therapeutics Inc (WHWK). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Whitehawk Therapeutics Inc Stock (WHWK) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Giacobello Scott M. | CHIEF FINANCIAL OFFICER |
Mar 03 '25 |
Sale |
2.35 |
2,806 |
6,594 |
23,944 |
| Lennon David James | CHIEF EXECUTIVE OFFICER |
Mar 03 '25 |
Sale |
2.35 |
5,690 |
13,372 |
33,429 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):